Overview

Relative Bioavailability of a Fentanyl Patch

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Fentanyl